BioRestorative Therapies, Inc. , a life sciences company focused on developing stem cell-based therapies for personal medical applications, announced the engagement of the regulatory consultancy firm Phil Triolo and Associates, LC to help advance the Company's brtxDISCa therapeutic procedure through the U.S. Food and Drug Administration regulatory ... (more)
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130930005192&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130930005192&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment